| UniProt ID | RN111_HUMAN | |
|---|---|---|
| UniProt AC | Q6ZNA4 | |
| Protein Name | E3 ubiquitin-protein ligase Arkadia {ECO:0000305|PubMed:14657019} | |
| Gene Name | RNF111 {ECO:0000312|HGNC:HGNC:17384} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 994 | |
| Subcellular Localization | Nucleus . Cytoplasm . Nucleus, PML body . Upon TGF-beta treatment, translocates from nucleus to cytosol. | |
| Protein Description | E3 ubiquitin-protein ligase. [PubMed: 26656854 Required for mesoderm patterning during embryonic development (By similarity Acts as an enhancer of the transcriptional responses of the SMAD2/SMAD3 effectors, which are activated downstream of BMP] | |
| Protein Sequence | MSQWTPEYNELYTLKVDMKSEIPSDAPKTQESLKGILLHPEPIGAAKSFPAGVEMINSKVGNEFSHLCDDSQKQEKEMNGNQQEQEKSLVVRKKRKSQQAGPSYVQNCVKENQGILGLRQHLGTPSDEDNDSSFSDCLSSPSSSLHFGDSDTVTSDEDKEVSVRHSQTILNAKSRSHSARSHKWPRTETESVSGLLMKRPCLHGSSLRRLPCRKRFVKNNSSQRTQKQKERILMQRKKREVLARRKYALLPSSSSSSENDLSSESSSSSSTEGEEDLFVSASENHQNNPAVPSGSIDEDVVVIEASSTPQVTANEEINVTSTDSEVEIVTVGESYRSRSTLGHSRSHWSQGSSSHASRPQEPRNRSRISTVIQPLRQNAAEVVDLTVDEDEPTVVPTTSARMESQATSASINNSNPSTSEQASDTASAVTSSQPSTVSETSATLTSNSTTGTSIGDDSRRTTSSAVTETGPPAMPRLPSCCPQHSPCGGSSQNHHALGHPHTSCFQQHGHHFQHHHHHHHTPHPAVPVSPSFSDPACPVERPPQVQAPCGANSSSGTSYHEQQALPVDLSNSGIRSHGSGSFHGASAFDPCCPVSSSRAAIFGHQAAAAAPSQPLSSIDGYGSSMVAQPQPQPPPQPSLSSCRHYMPPPYASLTRPLHHQASACPHSHGNPPPQTQPPPQVDYVIPHPVHAFHSQISSHATSHPVAPPPPTHLASTAAPIPQHLPPTHQPISHHIPATAPPAQRLHPHEVMQRMEVQRRRMMQHPTRAHERPPPHPHRMHPNYGHGHHIHVPQTMSSHPRQAPERSAWELGIEAGVTAATYTPGALHPHLAHYHAPPRLHHLQLGALPLMVPDMAGYPHIRYISSGLDGTSFRGPFRGNFEELIHLEERLGNVNRGASQGTIERCTYPHKYKKVTTDWFSQRKLHCKQDGEEGTEEDTEEKCTICLSILEEGEDVRRLPCMHLFHQVCVDQWLITNKKCPICRVDIEAQLPSES | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MSQWTPEYNELY ---CCCCCCCCCEEE | 9.90 | 28555341 | |
| 19 | Sumoylation | YTLKVDMKSEIPSDA EEEECCCCCCCCCCC | 40.24 | - | |
| 19 | Sumoylation | YTLKVDMKSEIPSDA EEEECCCCCCCCCCC | 40.24 | 28112733 | |
| 20 | Phosphorylation | TLKVDMKSEIPSDAP EEECCCCCCCCCCCC | 33.83 | - | |
| 24 (in isoform 2) | Phosphorylation | - | 52.66 | 24719451 | |
| 24 | Phosphorylation | DMKSEIPSDAPKTQE CCCCCCCCCCCCCHH | 52.66 | 24719451 | |
| 28 | Ubiquitination | EIPSDAPKTQESLKG CCCCCCCCCHHHHCC | 65.64 | - | |
| 28 | Sumoylation | EIPSDAPKTQESLKG CCCCCCCCCHHHHCC | 65.64 | 28112733 | |
| 34 | Sumoylation | PKTQESLKGILLHPE CCCHHHHCCEECCCC | 53.86 | - | |
| 34 (in isoform 3) | Ubiquitination | - | 53.86 | - | |
| 34 | Ubiquitination | PKTQESLKGILLHPE CCCHHHHCCEECCCC | 53.86 | - | |
| 34 | Sumoylation | PKTQESLKGILLHPE CCCHHHHCCEECCCC | 53.86 | 28112733 | |
| 47 | Sumoylation | PEPIGAAKSFPAGVE CCCCCCCCCCCCCCE | 52.69 | - | |
| 47 | Sumoylation | PEPIGAAKSFPAGVE CCCCCCCCCCCCCCE | 52.69 | 28112733 | |
| 47 | Acetylation | PEPIGAAKSFPAGVE CCCCCCCCCCCCCCE | 52.69 | 25953088 | |
| 47 | Ubiquitination | PEPIGAAKSFPAGVE CCCCCCCCCCCCCCE | 52.69 | - | |
| 59 | Sumoylation | GVEMINSKVGNEFSH CCEEHHHHCCCHHHH | 50.07 | 28112733 | |
| 73 | Sumoylation | HLCDDSQKQEKEMNG HHCCHHHHHHHHHCC | 65.46 | - | |
| 73 | Ubiquitination | HLCDDSQKQEKEMNG HHCCHHHHHHHHHCC | 65.46 | - | |
| 73 | Sumoylation | HLCDDSQKQEKEMNG HHCCHHHHHHHHHCC | 65.46 | 28112733 | |
| 87 | Ubiquitination | GNQQEQEKSLVVRKK CCHHHHHHHHHHHHH | 49.11 | - | |
| 87 (in isoform 3) | Ubiquitination | - | 49.11 | - | |
| 87 | Sumoylation | GNQQEQEKSLVVRKK CCHHHHHHHHHHHHH | 49.11 | 28112733 | |
| 96 | Sumoylation | LVVRKKRKSQQAGPS HHHHHHHHHHHCCHH | 62.59 | 28112733 | |
| 97 | Phosphorylation | VVRKKRKSQQAGPSY HHHHHHHHHHCCHHH | 31.40 | 25159151 | |
| 110 | Sumoylation | SYVQNCVKENQGILG HHHHHHHHHCCCEEC | 53.82 | 28112733 | |
| 162 | Phosphorylation | SDEDKEVSVRHSQTI CCCCCCEEEEHHHHH | 17.96 | 29496963 | |
| 173 | Ubiquitination | SQTILNAKSRSHSAR HHHHHHHHCCCCCCC | 45.38 | - | |
| 173 | Sumoylation | SQTILNAKSRSHSAR HHHHHHHHCCCCCCC | 45.38 | - | |
| 173 (in isoform 3) | Ubiquitination | - | 45.38 | - | |
| 173 | Sumoylation | SQTILNAKSRSHSAR HHHHHHHHCCCCCCC | 45.38 | 28112733 | |
| 178 | Phosphorylation | NAKSRSHSARSHKWP HHHCCCCCCCCCCCC | 26.99 | 26329039 | |
| 198 | Sumoylation | SVSGLLMKRPCLHGS CCCHHHHCCCCCCCC | 53.83 | 28112733 | |
| 205 | Phosphorylation | KRPCLHGSSLRRLPC CCCCCCCCHHCCCCC | 18.56 | 28555341 | |
| 206 | Phosphorylation | RPCLHGSSLRRLPCR CCCCCCCHHCCCCCH | 30.41 | 28555341 | |
| 218 | Ubiquitination | PCRKRFVKNNSSQRT CCHHHHHHCCCCHHH | 47.93 | - | |
| 218 | Sumoylation | PCRKRFVKNNSSQRT CCHHHHHHCCCCHHH | 47.93 | 28112733 | |
| 221 | Phosphorylation | KRFVKNNSSQRTQKQ HHHHHCCCCHHHHHH | 36.92 | 29759185 | |
| 222 | Phosphorylation | RFVKNNSSQRTQKQK HHHHCCCCHHHHHHH | 26.29 | 29759185 | |
| 339 | Phosphorylation | GESYRSRSTLGHSRS CCCCCCCCCCCCCCC | 29.27 | - | |
| 349 | Phosphorylation | GHSRSHWSQGSSSHA CCCCCCCCCCCCCCC | 21.17 | 28348404 | |
| 352 | Phosphorylation | RSHWSQGSSSHASRP CCCCCCCCCCCCCCC | 22.49 | 28348404 | |
| 353 | Phosphorylation | SHWSQGSSSHASRPQ CCCCCCCCCCCCCCC | 32.73 | 28348404 | |
| 354 | Phosphorylation | HWSQGSSSHASRPQE CCCCCCCCCCCCCCC | 25.44 | 28348404 | |
| 369 | Phosphorylation | PRNRSRISTVIQPLR CCCHHHHHHHHHHHH | 18.60 | 28555341 | |
| 370 | Phosphorylation | RNRSRISTVIQPLRQ CCHHHHHHHHHHHHH | 21.18 | 28555341 | |
| 461 | Phosphorylation | IGDDSRRTTSSAVTE CCCCCCCCCCCCCCC | 29.89 | 22210691 | |
| 576 | Phosphorylation | LSNSGIRSHGSGSFH CCCCCCCCCCCCCCC | 30.22 | 27080861 | |
| 579 | Phosphorylation | SGIRSHGSGSFHGAS CCCCCCCCCCCCCCC | 26.32 | 27080861 | |
| 581 | Phosphorylation | IRSHGSGSFHGASAF CCCCCCCCCCCCCCC | 18.77 | 27080861 | |
| 586 | Phosphorylation | SGSFHGASAFDPCCP CCCCCCCCCCCCCCC | 33.78 | 27080861 | |
| 783 | Phosphorylation | PHRMHPNYGHGHHIH CCCCCCCCCCCCCCC | 18.23 | - | |
| 861 | Dimethylation | MAGYPHIRYISSGLD CCCCCCEEEEECCCC | 21.50 | - | |
| 861 | Methylation | MAGYPHIRYISSGLD CCCCCCEEEEECCCC | 21.50 | 54561739 | |
| 895 | Methylation | ERLGNVNRGASQGTI HHHCCCCCCCCCCHH | 37.46 | 115491367 | |
| 898 | Phosphorylation | GNVNRGASQGTIERC CCCCCCCCCCHHCCC | 31.78 | - | |
| 923 | Sumoylation | TDWFSQRKLHCKQDG CCHHHHCCEECCCCC | 34.64 | 28112733 | |
| 923 | Ubiquitination | TDWFSQRKLHCKQDG CCHHHHCCEECCCCC | 34.64 | - | |
| 927 | Ubiquitination | SQRKLHCKQDGEEGT HHCCEECCCCCCCCC | 40.45 | - | |
| 927 | Sumoylation | SQRKLHCKQDGEEGT HHCCEECCCCCCCCC | 40.45 | - | |
| 927 | Sumoylation | SQRKLHCKQDGEEGT HHCCEECCCCCCCCC | 40.45 | 28112733 | |
| 932 (in isoform 3) | Ubiquitination | - | 76.56 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RN111_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RN111_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RN111_HUMAN !! | ||||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...